Chemfab Alkalis Limited (NSE: CHEMFAB)
India
· Delayed Price · Currency is INR | Market Cap | 13.14B |
| Revenue (ttm) | 3.27B |
| Net Income (ttm) | 128.73M |
| Shares Out | 14.29M |
| EPS (ttm) | 8.93 |
| PE Ratio | 102.96 |
| Forward PE | n/a |
| Dividend | 1.25 (0.14%) |
| Ex-Dividend Date | Sep 13, 2024 |
| Volume | 6,373 |
| Open | 937.10 |
| Previous Close | 937.10 |
| Day's Range | 913.50 - 937.10 |
| 52-Week Range | 353.60 - 1,230.00 |
| Beta | 0.15 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 14, 2024 |
About Chemfab Alkalis
Chemfab Alkalis Limited, together with its subsidiary, Chemfab Alkalis Karaikal Limited, manufactures and sells inorganic chemicals in India and internationally. The company operates through Chemicals and Related Products/Services; and PVC-O Pipes segments. The company offers caustic soda lye and flakes, liquid chlorine, hydrogen gas, hydrochloric acid, and sodium hypochlorite/bleach liquor products; sodium chlorate; aluminum chloride; and alkali, acids, bases, solvents, alcohols, gases, ethers, aliphatics, aromatics, aldehydes ketones, amines,... [Read more]
Financial Performance
In 2023, Chemfab Alkalis's revenue was 3.27 billion, a decrease of -1.23% compared to the previous year's 3.31 billion. Earnings were 263.23 million, a decrease of -59.24%.
Financial StatementsNews
Chemfab Alkalis shares fall over 9% following weak Q2 FY25 results
Shares of Chemfab Alkalis Limited declined by 9.29%, trading at ₹1,007.25 on the NSE as of 9:22 am, following its Q2 FY2025 financial results. The company’s earnings report showed a decline in EBITDA ...